SCHEMBL6979093

SCHEMBL6979093

CC[CH]CC(=O)c1ccc(Br)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.53
HDAC1 Q13547 3/20 0.50
HDAC3 O15379 2/20 0.50
HDAC2 Q92769 2/20 0.50
HDAC8 Q9BY41 2/20 0.50
HDAC4 P56524 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
HDAC9 Q9UKV0 1/20 0.50
HDAC5 Q9UQL6 1/20 0.50
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
HPGD P15428 3/20 0.44
ALDH1A1 P00352 3/20 0.44
RAB9A P51151 3/20 0.44
NPC1 O15118 2/20 0.44
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6975977 0.80 GSK3B (0.57) GSK3BHDAC1HDAC3HDAC2HDAC8
SCHEMBL8975154 0.78 HDAC1 (0.61) GSK3BHDAC1HDAC3HDAC2HDAC8
SCHEMBL301100 0.77 GSK3B (0.64) GSK3BHDAC1HDAC3HDAC2HDAC8
SCHEMBL3412166 0.76 GSK3B (0.57) GSK3BHDAC1HDAC3HDAC2HDAC8
Water SCHEMBL27991728 0.76 HDAC1 (0.59) GSK3BHDAC1HDAC3HDAC2HDAC8
SCHEMBL2116189 0.74 HSD17B3 (0.67) GSK3BHDAC1HDAC3HDAC2HDAC8
Ethylene SCHEMBL11738819 0.74 GSK3B (0.59) GSK3BHDAC1HDAC3HDAC2HDAC8
SCHEMBL11555145 0.73 GSK3B (0.53) GSK3BHDAC1HDAC3HDAC2HDAC8
Methoxyamine SCHEMBL27908334 0.73 HDAC1 (0.50) GSK3BHDAC1HDAC3HDAC2HDAC8
SCHEMBL8987897 0.72 SMN1; SMN2 (0.68) GSK3BHDAC1HDAC3HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206262-A4 NPY ANTAGONISTS: SPIROISOQUINOLINONE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2003-01-02 EP disclosed
EP-1206262-A1 NPY ANTAGONISTS: SPIROISOQUINOLINONE DERIVATIVES Bristol-Myers Squibb Company (US) 2002-05-22 EP disclosed
US-6348472-B1 ANOREXIGENIC AGENTS AND EATING DISORDERS BRISTOL-MYERS SQUIBB COMPANY 2002-02-19 US disclosed
WO-2001013917-A1 NPY ANTAGONISTS: SPIROISOQUINOLINONE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2001-03-01 WO disclosed